Skip to main content

Table 2 Guideline appraisal

From: Guidelines for the use of survivorship care plans: a systematic quality appraisal using the AGREE II instrument

Guideline Domain #1: scope and purpose Domain #2: stakeholder involvement Domain #3: rigor of development Domain #4: clarity of presentation Domain #5: applicability Domain #6: editorial independence Overall assessment Recommendation
Alberta Health Services 61% 35% 83% 63% 0% 75% 58% Recommended
American Cancer Society 33% 6% 7% 46% 4% 8% 8% Not recommended
American Society of Clinical Oncology 44% 36% 15% 75% 23% 46% 42% Not recommended
Association of Community Cancer Centers 19% 36% 2% 75% 4% 0% 17% Not recommended
Commission on Cancer 19% 33% 12% 88% 19% 0% 33% Not recommended
Comprehensive Cancer Center of the Netherlands 69% 75% 56% 96% 38% 42% 67% Recommended
International Myeloma Foundation 56% 42% 17% 63% 21% 96% 42% Not recommended
Institute of Medicine 22% 42% 12% 92% 38% 38% 50% Not recommended
LIVESTRONG 33% 22% 10% 96% 31% 0% 33% Not recommended
National Breast and Ovarian Cancer Centre 28% 58% 26% 46% 0% 63% 33% Not recommended
National Comprehensive Cancer Network 72% 58% 26% 67% 31% 42% 50% Not recommended
National Coalition for Cancer Survivorship/Institute of Medicine/Lance Armstrong Foundation/National Cancer Institute 92% 61% 18% 63% 52% 0% 58% Recommended
National Cancer Institute Community Cancer Centers Program 56% 42% 17% 88% 40% 29% 58% Recommended
National Collaborating Centre for Cancer 19% 86% 69% 79% 40% 29% 58% Recommended
President’s Cancer Panel 11% 92% 7% 92% 15% 0% 25% Not recommended
National Health Service 31% 39% 5% 42% 0% 0% 25% Not recommended